Avaliação do efeito da roxitromicina na regressão da hiperplasia gengival induzida pela Ciclosporina em ratos
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora (UFJF)
DOI
Abstract
Gingival overgrowth (GO) is a common side effect of the chronic use of
cyclosporine (CsA), an immunosuppressive drug which is widely used to prevent
organ rejection in transplant patients. Recent studies have shown elevated levels of
specific cytokines in hyperplastic gingival tissue, particularly TGF-ß, which suggests
that this growth factor plays a role in the accumulation of extracellular matrix in
gingival hyperplasia. Treatment for this complication, until recently, was only surgical.
Today, several studies have demonstrated the effectiveness of azithromycin, a
macrolide antibiotic, in the regression of this undesirable side effect caused by the
immunosuppressant. In this study, an experimental model for assessing the
therapeutic effect of roxithromycin in GO was created. We used four groups of mice
totaling 32 individuals. GO was induced during five weeks and drug treatment was
given on the 6th week as follows: group A – animals received saline; group B –
animals received CsA and were treated with saline on the 6th week; group C –
animals received CsA and, on the 6th week, ampicilin; and group D – animals
received CsA during 5 weeks and, on the 6th week, were treated with roxithromycin.
Therefore, this study evaluated the effect of roxithromycin in the treatment of GH.
Additionally, we investigated the expression of transforming growing factor beta
(TGF- 2) through an immunohistochemical technique (avidin-biotin-peroxidaseantiperoxidase
complex) in order to better understand the pathogenesis of GO.
Gingival mucosa showed a decrease of thickness with a lower number of fibroblasts,
with reduction of fibrosis areas and decrease of inflammatory infiltrate, and a
significant reduction of TGF- 2 expression in roxithromycin treated rats in comparison
with animals from the control groups. The present data suggest that the downregulation
of TGF- 2 expression may be an important mechanism of action by which
roxithromycin inhibits GO.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Rights and licensing
Acesso Aberto
